Influenza Vaccine Market to Reach US$ 2.5 Billion by 2022 Influenza Vaccine Market worth US$ 2.5 Billion | Page 2

Influenza Vaccine Market - United States Industry Analysis, Size, Share,
Growth, Trends and Forecasts – 2022
United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of
2022.
Influenza Vaccine Market growth can be attributed to factors such as increased disease awareness,
expanded recommendations by governmental and advisory bodies to be vaccinated against influenza
vaccine and introduction of quadrivalent influenza vaccine.
Company Coverage: Sanofi Pasteur,GlaxoSmithKline(GSK),Seqirus,AstraZenecca,Protein Sciences
Corporation,Novavax,Daiichi–Sankyo,Mitsubishi Tanabe Pharma,BiondVax Pharmaceuticals Ltd,VaxInnate
The research report presents a comprehensive assessment of the market and contains thoughtful insights,
facts, historical data, and statistically supported and industry–validated market data. It provides essential
insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses
distribution, production and offers a clear view of the regulatory landscape. Additionally, the report
includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market.
Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
Complete report available at http://www.marketreportsonline.com/542644.html